搜索临床试验以:Purinergic P1 Receptor Antagonists
总计9451个结果
-
University Hospital, GhentAstraZeneca完全的
-
University of FloridaChiesi Farmaceutici S.p.A.完全的
-
University of ZagrebClinical Hospital Centre Zagreb; Croatian Science Foundation完全的急性冠状动脉综合征 | 心肌梗死 | NSTEMI - 非 ST 段抬高 MI | 血小板聚集 | 个体化治疗克罗地亚
-
Region SkaneAstraZeneca; IHF GmbH - Institut für Herzinfarktforschung; Hippocrates Research; IRW consulting AB撤销糖尿病 | 微血管冠状动脉疾病
-
Hospital Clinic of BarcelonaAstraZeneca完全的计划接受 CTO(慢性完全闭塞)PCI(经皮冠状动脉介入治疗)的患者西班牙
-
Seung-Jung ParkCardioVascular Research Foundation, Korea完全的
-
Kowa Research Institute, Inc.完全的
-
General Hospital of Chinese Armed Police Forces完全的
-
Daewoong Pharmaceutical Co. LTD.未知
-
Emory University完全的
-
Assistance Publique - Hôpitaux de Paris完全的
-
SanofiBristol-Myers Squibb完全的
-
University Hospital, BordeauxMinistry for Health and Solidarity, France招聘中
-
J.M. ten BergAstraZeneca未知
-
IHF GmbH - Institut für Herzinfarktforschung完全的
-
Astellas Pharma Global Development, Inc.完全的
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI); Spartan Bioscience Inc.; Applied Health Research...完全的
-
Peking University Third HospitalAstraZeneca Investment (China) Co., Ltd完全的
-
First Affiliated Hospital of Harbin Medical UniversityRenJi Hospital; Shengjing Hospital; Beijing Anzhen Hospital; Shaanxi Provincial People's Hospital; Wuhan Union Hospital, China 和其他合作者完全的
-
Jiangsu vcare pharmaceutical technology co., LTD完全的
-
First Affiliated Hospital of Harbin Medical University未知
-
Catholic University of the Sacred Heart终止
-
Assistance Publique Hopitaux De Marseille完全的